Nuvalent Corp - Wutah bathi EPS kuartalan NUVL

Logo korporat perusahaan Nuvalent (NUVL)

Amidst fierce competition with pharma behemoths, where development speed is everything, the quarterly change in earnings per share helps assess the market prospects of Nuvalent, Inc. (NUVL). The value -17.50 represents the current value of this metric. The issuer relies on partnerships with oncology centers to create precise kinase inhibitors, developing innovative treatments for mutated forms of cancer that are resistant to conventional medications.

Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan nuvalent.com (NUVL): kanggo periode 04.07.2022 - 25.07.2026

Rincian analitis perusahaan Nuvalent, Inc.

- rega saham lan konsensus proyeksi valuasi:
Pambiji fundamental perusahaan:nuvalent.com - NUVL
Barang unggulan nuvalent.com

Nuvalent, Inc. (NUVL) develops targeted oncology drugs, operating without commercial revenue by relying on investment capital. The absence of revenue makes the earnings per share calculation a derivative of the cash burn rate and operating expenses. This metric measures the dynamics of net income per share on a quarterly basis. Analyzing the quarterly EPS percentage change on GURU.Markets allows for tracking the sustainability of the issuer's financial reserves. Sharp fluctuations in this chart signal risks of accelerated liquidity depletion.

Analisis perusahaan pesaing

GMAB (Genmab) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|EXEL: Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|KYMR (Kymera Corp) - Wutah bathi EPS kuartalan|Wutah bathi EPS kuartalan ideayabio.com|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Enliven Therapeutics, Inc. (ELVN)|ORIC (ORIC Pharmaceuticals, Inc.) - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan RLAY (Relay Therapeutics Inc)|Wutah bathi resik saben saham sajroning taun lumaku Nurix Pharma|Tyra Biosciences Inc - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Verastem|GLUE (Monte Rosa Therapeutics) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|CGEM: Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|IMRX (immuneering.com) - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan C4 Tx CCCC|Wutah bathi EPS kuartalan BDTX|Repare Therapeutics Inc. - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|PMV Pharmaceuticals, Inc. - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan KPTI|PPCB: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Cyclacel Pharmaceuticals - Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|AADI: Wutah bathi EPS kuartalan|Aileron Therapeutics Inc - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|BPMC (Blueprint Medicines Corp.) - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan glycomimetics.com GLYC|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan SpringWorks (SWTX)